Screener
KAUG vs PJP
Innovator U.S. Small Cap Power Buffer ETF - August vs Invesco Pharmaceuticals ETF
Key differences
- PJP costs 0.22% less per year.
- PJP is significantly larger than KAUG — larger funds tend to be more liquid and less likely to close.
- KAUG is classified as alternative, while PJP is equity — different risk/return profiles.
- KAUG follows a structured outcome strategy; PJP uses index tracking.
- PJP has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| KAUG | PJP | |
|---|---|---|
| Annual cost (TER) | 0.79% | 0.57% |
| Fund size (AUM) | $80M | $334M |
| Since | 2024 | 2005 |
| Dividend yield | 0.00% | 1.01% |
| Asset class | alternative | equity |
| Region | north america | north america |
| Strategy | structured outcome | index tracking |
| CAGR 1Y | +17.0% | +40.6% |
| CAGR 3Y | N/A | +14.0% |
| CAGR 5Y | N/A | +7.8% |
| Sharpe 3Y | N/A | 0.69 |
| Volatility 1Y | 8.09% | 16.23% |
| Max drawdown | -15.66% | -33.95% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to KAUG and PJP
Explore further